Citation Impact

Citing Papers

Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
2007 StandoutNobel
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
The microbiota regulates type 2 immunity through RORγt + T cells
2015 StandoutScienceNobel
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
2018
The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis
2008
Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice
2003
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Interferons as pathogenic effectors in autoimmunity
2005
Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis
2008
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.
1989
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
1999 StandoutNobel
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
Hyperuricemia as a Predictor of Hypertension in a Screened Cohort in Okinawa, Japan
2004
Uric Acid and Cardiovascular Risk
2008 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination
1990
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Inflammatory Bowel Disease
2009 Standout
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
2005 StandoutNobel
Cytokines in autoimmunity
1996
DNA Damage, Aging, and Cancer
2009 Standout
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Inflammatory Bowel Disease
2002 Standout
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
2018
T-cell antigen receptor genes and T-cell recognition
1988 StandoutNature
Differential expression of mucosal addressin cell adhesion molecule‐1 (MAdCAM‐1) in ulcerative colitis and Crohn's disease
2002
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Analysis of tumor necrosis factor promoter responses to ultraviolet light.
1994 StandoutNobel
S20G mutation of the amylin gene is associated with Type II diabetes in Japanese
2001
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
A microbial symbiosis factor prevents intestinal inflammatory disease
2008 StandoutNature
The molecular classification of the clinical manifestations of Crohn's disease
2002
Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine
2007
The Genetics of Inflammatory Bowel Disease
2007
HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
1987 StandoutNature
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Genetic Variation in the Hypoxia-Inducible Factor-1α Gene Is Associated with Type 2 Diabetes in Japanese
2005
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity
2004
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
2008 StandoutNature
Inflammasomes in health and disease
2012 StandoutNature
Cytokines in autoimmunity
1992
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Reshaping Human Antibodies: Grafting an Antilysozyme Activity
1988 StandoutScienceNobel
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice
2003
Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease
2002
Primary Biliary Cirrhosis
1987 Standout
T-Cell Compartments of Prediabetic NOD Mice
2003
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Direct Correlation Between Ischemic Injury and Extracellular Glycine Concentration in Mice With Genetically Altered Activities of the Glycine Cleavage Multienzyme System
2007
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy
1990
Anti‐acetylcholine Receptor Antibodies in Primary Biliary Cirrhosis
1985
Murine Models of Systemic Lupus Erythematosus
1985
Cytokine Storm
2020 Standout
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
2005 StandoutScience
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice
2002 StandoutNobel
Molecular Mechanisms RegulatinG Th1 Immune Responses
2003
THE NOD MOUSE: A Model of Immune Dysregulation
2004
Promoter and enhancer elements in the rearranged alpha chain gene of the human T cell receptor.
1987
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
2004 StandoutNobel
Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.
1987
Overview of Castleman disease
2020
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.
1994 StandoutNobel
RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates
2006 StandoutScience
NOD mice have a generalized defect in their response to transplantation tolerance induction.
1999
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Human lymphocyte Hybridomas and Monoclonal Antibodies
1986

Works of Jo Satoh being referenced

WRN gene 1367 Arg allele protects against development of type 2 diabetes mellitus
2005
Complete Suppression of Insulitis and Diabetes in NOD mice Lacking Interferon Regulatory Factor-1
2001
Report of the Committee on the classification and diagnostic criteria of diabetes mellitus
2002
Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats
1992
Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene
1999
Structure and expression of the glycine cleavage system in rat central nervous system
2001
Immunologic Aspects of the Nonobese Diabetic (NOD) Mouse: Abnormalities of Cellular Immunity
1983
Streptococcal Preparation (OK-432) Inhibits Development of Type I Diabetes in NOD Mice
1986
Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
2018
NOD mice with high incidence of type 1 diabetes are not T lymphocytopenic.
1988
Treatment With Streptococcal Preparation (OK-432) Suppresses Anti-Islet Autoimmunity and Prevents Diabetes in BB Rats
1988
Human Monoclonal Autoantibodies That React with Multiple Endocrine Organs
1983
A case of TAFRO syndrome, a variant of multicentric Castleman’s disease, successfully treated with corticosteroid and cyclosporine A
2016
Rankless by CCL
2026